Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials

Hung-Yang Kuo & Robert S. Kerbel et al. · 2024

Links
Authors
Hung-Yang Kuo, Kabir A. Khan, Robert S. Kerbel